April 2022
1. JAFFE S
   Medicare covers new Alzheimer's drug, but there is a catch.
   Lancet. 2022;399:1585.
   

   >> Share

   
   September 2021
2. SCHELTENS P
   Responding to responsive behaviour in Alzheimer's disease - Author's reply.
   Lancet. 2021;398:842.
   

   >> Share

   
   
3. O'NEILL D, Kennelly S
   Responding to responsive behaviour in Alzheimer's disease.
   Lancet. 2021;398:842.
   

   >> Share

   
   July 2021
4. JAFFE S
   US FDA defends approval of Alzheimer's disease drug.
   Lancet. 2021;398:12.
   

   >> Share

   
   March 2021
5. SCHELTENS P, De Strooper B, Kivipelto M, Holstege H, et al
   Alzheimer's disease.
   Lancet. 2021 Mar 2. pii: S0140-6736(20)32205.
   

   >> Share

   
   February 2021
6. SIVA N
   New global initiative to tackle Alzheimer's disease.
   Lancet. 2021;397:568-569.
   

   >> Share

   
   June 2020
7. FORTEA J, Vilaplana E, Carmona-Iragui M, Benejam B, et al
   Clinical and biomarker changes of Alzheimer's disease in adults with Down syndrome: a cross-sectional study.
   Lancet. 2020;395:1988-1997.
   

   >> Share

   
   
8. HEAD E, Ances B
   Biomarkers in Down syndrome can help us understand Alzheimer's disease.
   Lancet. 2020;395:1951-1953.
   

   >> Share

   
   February 2020
9. SEN A, Jette N, Husain M, Sander JW, et al
   Epilepsy in older people.
   Lancet. 2020;395:735-748.
   

   >> Share

   
   
10. WATTS G
    Giovanna Mallucci: redefining neurodegeneration.
    Lancet. 2020;395:486.
    

    >> Share

    
    September 2019
11. KEUSS SE, Bowen J, Schott JM
    Looking beyond the eyes: visual impairment in posterior cortical atrophy.
    Lancet. 2019;394:1055.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share